Posted by Two Blokes
ACN tops third-quarter fiscal 2025 estimates with 11.5% y/y EPS growth and 7.7% revenue gain, lifting the FY25
Source: Two Blokes Trading
Posted by Two Blokes
FLS gains from strong bookings and the MOGAS acquisition, but rising costs and high debt weigh on investor sen
Source: Two Blokes Trading
Posted by Two Blokes
Pfizer's broader portfolio and higher dividend yield give it an edge over Bristol Myers in the oncology showdo
Source: Two Blokes Trading
Posted by Two Blokes
CVNA's record Q1 sales and rising momentum set the stage for a possible fifth straight quarter of growth.
Source: Two Blokes Trading
Posted by Two Blokes
SNY and REGN's Dupixent gets FDA approval for a rare and chronic skin disease, marking its eighth approved ind
Source: Two Blokes Trading
Posted by Two Blokes
DIS commits $60 billion to expand parks and cruises, betting on global growth as strong bookings boost 2025 ou
Source: Two Blokes Trading
Posted by Two Blokes
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Za
Source: Two Blokes Trading
Posted by Two Blokes
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Styl
Source: Two Blokes Trading
Posted by Two Blokes
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Za
Source: Two Blokes Trading
Posted by Two Blokes
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Za
Source: Two Blokes Trading
Posted by Two Blokes
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Za
Source: Two Blokes Trading
Posted by Two Blokes
Despite recent underperformance and weak top/bottom line results, Spectrum Brands shares remain attractively v
Source: Two Blokes Trading